tiprankstipranks
Better Therapeutics Issues Investor Presentation with Cautions
PremiumCompany AnnouncementsBetter Therapeutics Issues Investor Presentation with Cautions
4M ago
Better Therapeutics CEO Discusses Future on Bloomberg TV
PremiumCompany Announcements
Better Therapeutics CEO Discusses Future on Bloomberg TV
4M ago
Better Therapeutics enters rebate pact with PBM for AspyreRx diabetes treatment
PremiumThe Fly
Better Therapeutics enters rebate pact with PBM for AspyreRx diabetes treatment
5M ago
Better Therapeutics reports Q3 EPS (15c), consensus (21c)
PremiumThe FlyBetter Therapeutics reports Q3 EPS (15c), consensus (21c)
8M ago
Better Therapeutics announces topline findings from AspyreRx analysis
PremiumThe Fly
Better Therapeutics announces topline findings from AspyreRx analysis
9M ago
Better Therapeutics’ LivVita study met primary endpoint by reducing liver fat
PremiumThe Fly
Better Therapeutics’ LivVita study met primary endpoint by reducing liver fat
9M ago
Better Therapeutics issues $6.7M in common stock under its at-the-market program
PremiumThe FlyBetter Therapeutics issues $6.7M in common stock under its at-the-market program
12M ago
Better Therapeutics receives FDA authorization for AspyreRx
PremiumThe Fly
Better Therapeutics receives FDA authorization for AspyreRx
12M ago
Is BTTX a Buy, Before Earnings?
PremiumPre-Earnings
Is BTTX a Buy, Before Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100